COVID-19 patients are being treated with drugs such as itolizumab even though there is insufficient evidence on their efficacy against the disease Divya Trivedi Siddhartha Das Venkitesh Ramakrishnan Some pharma companies appear to be using the ongoing pandemic as an excuse to bypass some ...
